We investigated the effect of intrapenile injection of muscle-derived cells (MDC) on the erectile function in rats with bilateral cavernous nerve injury. Rat MDC were harvested and transduced with a retrovirus expressing the lacZ gene. Hanks' balanced salt solution (HBSS) (20 ll) or MDC (1 Â 10 6 cells/side) were injected in each corpora cavernosa immediately before bilateral cavernous nerve transection. Intracavernous pressures (ICP) were measured 2 or 4 weeks after surgery with electrical stimulation of the pelvic nerves. Mean maximal ICP of sham group was significantly lower than that of control group both at 2 and 4 weeks after surgery. When MDC were injected into the penis, ICP improved over the sham-injected group at both 2 and 4 weeks after surgery. Percent area of PGP 9.5 staining was significantly greater in MDC-injected penis than in sham-injected at 2 and 4 weeks. Penile MDC injection can facilitate recovery of injured penile innervation and improve erectile function.
Introduction
Erectile dysfunction (ED) resulting from cavernous nerve injury is a major complication after extirpative surgery of a pelvic organ such as the prostate, bladder or rectum. Despite advances of surgical technique, ED occurs commonly in men who require radical prostatectomy. 1 In those in whom erections do return, recovery can be protracted, with slow improvements in the initiation and sustaining of an erection observed up to 36 months postoperatively. 2, 3 The trauma associated with removing the prostate overlying the neurovascular bundles can produce neuropraxia. Furthermore, local inflammation and immune response may also contribute to sexual dysfunction. Along with ED, some of these men complain about a decrease in the size of their penis. 4 To promote the recovery of erectile function, one line of research has been using cellular therapy to induce tissue and neural recovery. 5 There is evidence that pluripotent stem cells reside in the skeletal muscle. 6 Our group has extensive experience studying muscle-derived cells (MDC) with ability to improve function of skeletal and smooth muscle of the lower urinary tract. [7] [8] [9] [10] [11] [12] We have previously demonstrated that MDC injection into the damaged bladder 13 and urethra 14 can improve continence and muscle contractility with evidence of reinnervation. 15 Therefore, pluripotent stem cells isolated from adult muscle could provide a novel source for autologous cell replacement in muscle damage condition and also neurodegenerative and demyelinating disease. 16 The goal of the present study was to determine whether MDC could improve erectile function in a model of bilateral cavernous nerve transection.
Materials and methods

Experimental animals
The University of Pittsburgh Institutional Animal Care and Use Committee approved the experimental protocol. Adult male Sprague-Dawley (SD) rats (Hilltop Lab Animals, Inc., Scottdale, PA, USA), weighing about 350 g were used. Five experimental groups were included: a control group (n ¼ 6); a bilateral cavernous nerve transected group with MDC injections (1 Â 10 6 cells in 20 ml of Hanks' balanced salt solution (HBSS)/each side) into the penis, and studied at 2 weeks (n ¼ 6), and 4 weeks (n ¼ 6); and a bilateral cavernous nerve transected group with HBSS injections (20 ml/each side) into the penis as a sham-injected group, and studied at 2 weeks (n ¼ 6), and 4 weeks (n ¼ 6).
Purification of MDC MDC were taken from gastrocnemius muscle of female SD rat by preplate technique as previously described. 17 Briefly, a muscle biopsy was obtained from the whole hind limb muscle under sterile conditions. Cells were enzymatically dissociated by the addition of collagenase-type XI 0.2% for 1 h at 371C, dispase (grade II 240 unit) for 45 min, and trypsin 0.1% for 30 min. The dissociated cells were placed on a collagen-coated flask for 1 h. The first preplate flask (pp1) contained a majority of fibroblasts. The nonadhering cells were then transferred to another collagen-coated flask for 1 h to obtain pp2. This procedure was then repeated in 24 h intervals until pp6. The pp6 population that was used in this study was highly enriched for desmin, a marker of myogenic cells. The proliferation medium was Dulbecco's modified Eagle's medium with 10% fetal bovine serum, 10% horse serum, 0.5% chick embryo extract, and 1% penicillin/streptomycin. All culture media and other supplies were purchased from Gibco Laboratories (Grand Island, NY, USA). Late preplating allogenic rat MDC were transduced with retrovirus carrying the b-galactosidase reporter gene. MDC were plated at a density of 1-1.5 Â 10 6 in T 75 flasks, rinsed in HBSS, and incubated with MFG-NB, a retroviral vector containing the modified lacZ gene, nls-lacZ. 18 The titer of the viral stock was 1 Â 10 9 colony-forming units per ml. The transduction was performed in the presence of 8 mg/ml polybrene to improve the attachment of the retrovirus to MDC. After an initial incubation period of 28 h at 371C, MDC were detached using 0.25% trypsin for 1 min and centrifuged for 5 min at 3500 r.p.m. Cell pellets were reconstituted in 20 ml of HBSS.
Cavernous nerve transection and MDC injection
Subcutaneous ampicillin (100 mg/kg) was administered before surgery. Under halothane anesthesia, a low midline abdominal incision was made. The penis was exposed and the base was loosely tied with cotton string so as to retain injected material in penis. Injections of MDC (1 Â 10 6 suspended in 20 ml of HBSS) or 20 ml of HBSS were delivered into bilateral corpora cavernosa with 28 G disposable syringe. The ligature was removed after 10 min. The areas posterolateral to the prostate were explored on both sides, and the cavernous nerves were identified and cut at 2-3 mm distal to major pelvic ganglion (MPG). Wound was closed with absorbable chromic suture.
Electrical stimulation and intracavernous pressures recording Rats were anesthetized by initial induction using halothane inhalation, followed by subcutaneous urethane (1.2 g/kg). Through a low midline abdominal incision, pelvic nerves, MPG, and cavernous nerves were exposed bilaterally. The skin and fascia overlying the penis were incised to expose the corpora cavernosa. A 25 G needle connected to polyethylene (PE) 20 tube was inserted into proximal corpus cavernosum to measure intracavernous pressures (ICP). A bipolar platinium electrode was used to directly stimulate the pelvic nerve just proximal to the MPG. The stimulus parameters were 20 Hz, 10 V, 0.6 ms for longer than 30 s. ICP was measured three times with resting intervals of at least 10 min.
Histology
Immediately following ICP measurements, the penises were removed and the rats were killed with intravenous sodium pentobarbital (100 mg/kg). Tissue specimens were fixed in 4% paraformaldehyde overnight and then serially transferred into 10, 20 and 30% sucrose. Then they were embedded in OCT compound (Tissue-Tek, Miles Lab., Elkhard, Indiana) and sectioned at 10 mm on a cryostat (Microm, Walldorf, Germany). Sections were mounted on gelatin-coated slides. The slides were stained for H&E, PGP 9.5 (panneuronal marker) and lacZ, as described previously. 10 For the evaluation of nerve distribution, we estimated the percentage area positively stained with PGP 9.5 in the corpus cavernosum in six sections randomly selected from each rat using Image-Pro s Express software (Media Cybernetics, Silver Spring, MD, USA).
Statistical analysis
All data are presented as mean7s.e.m., and P-values o0.05 are reported as significant. Overall comparisons between groups were performed using Prism statistical software (GraphPad Software, Inc., San Diego, CA, USA). ANOVA test with Tukey or Bonferroni post test was used to compare results among control, sham-injected and MDC-injected groups.
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Results
We observed no acute or chronic morbidity or mortality from MDC injection into the penis. All animals survived for the entire duration of the experiment without urinary retention, infection or priapism. Histology Figure 2 demonstrates the lacZ staining of the corpus cavernosum in rats with bilateral cavernous nerve transected and intracavernous MDC injected. Cells expressing b-galactosidase stained as blue are seen within corpus cavernosum. Figure 3 shows PGP 9.5 staining within control, sham-injected and MDC-injected groups. Percent area of PGP 9.5 staining was significantly lower in sham group at 2 and 4 weeks after surgery compared to that of control group (0.8970.10, 1.0470.09 and 1.6170.16, respectively, Po0.05). Percent area of PGP 9.5 was significantly greater in MDC-injected at 2 and 4 weeks after surgery (2.1070.24 and 1.8170.16, respectively) compared with shaminjected group (Po0.05) (Figure 4 ).
Maximal ICP recording
Discussion
Cellular tissue engineering holds considerable promise for tissue and organ repair. In the present study, we investigated the functional and anatomical evidence of peripheral nerve regeneration with either MDC or sham injection. After bilateral cavernous nerve transection, we observed a significant decrease for 4 weeks in maximal ICP after electrical stimulation of pelvic nerve. However, when MDC were injected into the penis, maximal ICP was significantly improved after both 2 and 4 weeks. In addition, there was a significant neuron decrease in the penis with bilateral cavernous nerve 
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transection, as demonstrated by the area of PGP 9.5 staining. With MDC injection, the density of PGP 9.5 immunohistochemistry was increased to higher than control level.
Result of the functional and anatomical assessment of repaired peripheral nerves demonstrated nerve fiber regeneration after MDC but not after sham injection. Although, the mechanism through 19 using fresh muscle for nerve repair showed that fresh muscle fibers are a source of trophic factors to support Schwann cells survival. Denervated Schwann cells that usually undergo progressive degeneration survived for a 25-month period without axon contact inside the intramuscular segment of the severed nerve, suggesting that the denervated muscle environment can produce factors that can suppress Schwann cell death for a long time in the absence of axons. In another study, Geuna et al. 20 demonstrated a large overexpression of a particular insoform of the glial growth factor neuregulin-1 (NRG-1) inside fresh muscle-enriched vein conduits. Bochinski et al. 21 isolated embryonic stem cells that had differentiated along the neural cell line and, using these cells intracavernosally, showed improved erectile function in a rat model of neurogenic impotence. They supposed that neural embryonic stem cells act either by presenting cellular substrate or production of growth factors, or reducing the amount of demyelination.
Our findings were surprising in that MDC is generally presumed to improve a deficient muscle function in the bladder and urethra. 9 In this experiment, we injected MDC only in the penis. The mechanisms of how erectile function improves after MDC injection remains to be elucidated. The increase in PGP 9.5 neuronal staining suggests that MDC protected penile nerve from atrophy after cavernous nerve transection. It is also possible that MDC may differentiate into a neuronal phenotype cells when injected into cavernosum. In addition, new muscle cells and fibers persisted in the penis without fibrosis. Both of these observations may contribute to the improved erectile function observed physiologically.
In summary, muscle-derived cells, when injected into the penis, can facilitate recovery of injured penile nerves and improve erectile function. These results suggest that postradical prostatectomy and other types of ED may be treated with intracorporal MDC injection. Penile function can be augmented with direct injection of MDC into the penis. 
